JCR Pharmaceuticals Co., Ltd. (4552.T)
JPY 610.0
(-0.81%)
JPY 610.0
(-0.81%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 44.13 JPY | 45.45% |
| 2022 | 30.34 JPY | -74.13% |
| 2021 | 117.26 JPY | 110.14% |
| 2020 | 55.80 JPY | 156.91% |
| 2019 | 21.72 JPY | -28.01% |
| 2018 | 30.17 JPY | 22.24% |
| 2017 | 24.68 JPY | 67.44% |
| 2016 | 14.74 JPY | 5.06% |
| 2015 | 14.03 JPY | 6.21% |
| 2014 | 13.21 JPY | 29.51% |
| 2013 | 10.20 JPY | 77.08% |
| 2012 | 5.76 JPY | 16.6% |
| 2011 | 4.94 JPY | -31.67% |
| 2010 | 7.23 JPY | -43.03% |
| 2009 | 12.69 JPY | 152.79% |
| 2008 | 5.02 JPY | 36.04% |
| 2007 | 3.69 JPY | 123.12% |
| 2006 | -15.96 JPY | -3092.0% |
| 2005 | -0.50 JPY | 96.95% |
| 2004 | -16.38 JPY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -7.14 JPY | 126.28% |
| 2024 Q1 | 1.61 JPY | 691.41% |
| 2023 Q3 | -0.74 JPY | -102.54% |
| 2023 Q4 | 2.78 JPY | 475.68% |
| 2023 FY | - JPY | 45.45% |
| 2023 Q1 | 12.90 JPY | 691.41% |
| 2023 Q2 | 29.19 JPY | 126.28% |
| 2022 Q4 | 1.63 JPY | -92.2% |
| 2022 FY | - JPY | -74.13% |
| 2022 Q1 | 11.05 JPY | -13.74% |
| 2022 Q2 | -3.27 JPY | -129.59% |
| 2022 Q3 | 20.89 JPY | 738.84% |
| 2021 Q4 | 12.81 JPY | -57.0% |
| 2021 Q3 | 29.79 JPY | -52.15% |
| 2021 FY | - JPY | 110.14% |
| 2021 Q1 | 12.40 JPY | -57.78% |
| 2021 Q2 | 62.26 JPY | 402.1% |
| 2020 Q3 | 16.50 JPY | 343.55% |
| 2020 Q4 | 29.37 JPY | 78.0% |
| 2020 FY | - JPY | 156.91% |
| 2020 Q1 | 6.22 JPY | -12.02% |
| 2020 Q2 | 3.72 JPY | -40.19% |
| 2019 Q3 | 7.16 JPY | 59.47% |
| 2019 Q2 | 4.49 JPY | 49.67% |
| 2019 Q1 | 3.00 JPY | -80.01% |
| 2019 FY | - JPY | -28.01% |
| 2019 Q4 | 7.07 JPY | -1.26% |
| 2018 FY | - JPY | 22.24% |
| 2018 Q2 | 8.89 JPY | 286.52% |
| 2018 Q3 | 3.98 JPY | -55.23% |
| 2018 Q4 | 15.01 JPY | 277.14% |
| 2018 Q1 | 2.30 JPY | -51.98% |
| 2017 Q2 | 11.04 JPY | 180.92% |
| 2017 FY | - JPY | 67.44% |
| 2017 Q4 | 4.79 JPY | -2.84% |
| 2017 Q3 | 4.93 JPY | -55.34% |
| 2017 Q1 | 3.93 JPY | 11.02% |
| 2016 Q2 | 5.88 JPY | 167.27% |
| 2016 Q1 | 2.20 JPY | 11.11% |
| 2016 FY | - JPY | 5.06% |
| 2016 Q4 | 3.54 JPY | 13.46% |
| 2016 Q3 | 3.12 JPY | -46.94% |
| 2015 Q1 | 3.52 JPY | -41.14% |
| 2015 Q4 | 1.98 JPY | -47.06% |
| 2015 FY | - JPY | 6.21% |
| 2015 Q3 | 3.74 JPY | -21.92% |
| 2015 Q2 | 4.79 JPY | 36.08% |
| 2014 FY | - JPY | 29.51% |
| 2014 Q2 | 1.52 JPY | -28.3% |
| 2014 Q3 | 3.60 JPY | 136.84% |
| 2014 Q4 | 5.98 JPY | 66.11% |
| 2014 Q1 | 2.12 JPY | 85.96% |
| 2013 Q3 | 5.60 JPY | 275.84% |
| 2013 Q4 | 1.14 JPY | -79.64% |
| 2013 Q2 | 1.49 JPY | -23.98% |
| 2013 Q1 | 1.96 JPY | -32.18% |
| 2013 FY | - JPY | 77.08% |
| 2012 Q2 | 1.16 JPY | 132.0% |
| 2012 Q4 | 2.89 JPY | 138.84% |
| 2012 FY | - JPY | 16.6% |
| 2012 Q1 | 0.50 JPY | -39.02% |
| 2012 Q3 | 1.21 JPY | 4.31% |
| 2011 Q3 | 1.60 JPY | -0.62% |
| 2011 Q2 | 1.61 JPY | 76.92% |
| 2011 Q1 | 0.91 JPY | -14.15% |
| 2011 FY | - JPY | -31.67% |
| 2011 Q4 | 0.82 JPY | -48.75% |
| 2010 Q1 | 4.41 JPY | 748.08% |
| 2010 Q4 | 1.06 JPY | -24.82% |
| 2010 FY | - JPY | -43.03% |
| 2010 Q3 | 1.41 JPY | 235.71% |
| 2010 Q2 | 0.42 JPY | -90.48% |
| 2009 Q3 | 10.60 JPY | 915.38% |
| 2009 Q4 | 0.52 JPY | -95.09% |
| 2009 FY | - JPY | 152.79% |
| 2009 Q2 | -1.30 JPY | -154.62% |
| 2009 Q1 | 2.38 JPY | -20.4% |
| 2008 Q4 | 2.99 JPY | -43.69% |
| 2008 FY | - JPY | 36.04% |
| 2008 Q3 | 5.31 JPY | 538.84% |
| 2008 Q2 | -1.21 JPY | 0.0% |
| 2007 FY | - JPY | 123.12% |
| 2006 FY | - JPY | -3092.0% |
| 2005 FY | - JPY | 96.95% |
| 2004 FY | - JPY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Kyowa Kirin Co., Ltd. | 151.03 JPY | 70.781% |
| Astellas Pharma Inc. | 9.50 JPY | -364.526% |
| Chugai Pharmaceutical Co., Ltd. | 197.83 JPY | 77.693% |
| Ono Pharmaceutical Co., Ltd. | 266.61 JPY | 83.448% |
| Santen Pharmaceutical Co., Ltd. | 72.62 JPY | 39.232% |
| Daiichi Sankyo Company, Limited | 104.69 JPY | 57.847% |
| Otsuka Holdings Co., Ltd. | 224.11 JPY | 80.309% |
| Perseus Proteomics Inc. | -93.69 JPY | 147.102% |